Prevalence of cardiovascular diseases in patients with chronic kidney diseases
CHEN Xiaonong,PAN Xiaoxia,YU Haijin,SHEN Pingyan,ZHANG Qianying,ZHANG Wen,REN Hong,QIAN Ying,ZHU Ping,CHEN Nan
2009-01-01
Abstract:Objective To investigate the prevalence of cardiovascular diseases (CVD) in patients with chronic kidney disease (CKD) stage 1-5, so as to provide more information for prevention and treatment of CVD in CKD patients. Methods Six hundred and two CKD patients, who were hospitalized in Ruijin Hospital between Jan. of 2004 and Jan. of 2006, were surveyed using questionnaire to collect patients history and laboratory data. Results The ratios of patients at CKD stage 1, 2, 3, 4, and 5 were 12.96%, 14.45%, 23.26%, 12.96%, and 36.38%, respectively. The prevalences of CVD in patients with CKD stage 1—5 were 5.13%(4/78), 17.24%(15/87), 27.86%(39/140), 26.92%(21/78), and 47.49%(104/219), respectively. The prevalence of coronary artery disease (CAD) in CKD patients was 8.64% (52/602), of left ventricular hypertrophy (LVH) was 25.58%(154/602), and of congestive heart failure (CHF) was 12.96%(78/602). The prevalences of CAD in patients with CKD stage 1—5 were 1.28%(1/78), 5.75%(5/87), 7.86%(11/140), 10.26%(8/78), and 12.33%(27/219);those of LVH were 0,11.49%(10/87), 16.43%(23/140), 29.49%(23/78), and 44.75%(98/219);and those of CHF were 0, 3.45%(3/87), 3.57%(5/140), 8.97%(7/78), and 28.77%(63/219), respectively. The prevalences of CAD,LVH, and CHF were 33.06%, 53.72%, and 45.45%, respectively. Ultrasonic cardiography (UCG), electrocardiogram (ECG) and chest X-ray showed that the incidence of cardiovascular abnormalities in maintenance dialysis patients increased with the progression of CKD. The abnormal rates of different methods from higher to lower were UCG, ECG and chest X-ray. Conclusion CVD may occur at CKD stage 1, and the incidence increases with the progression of CKD. The most common form of CVD is LVH, which is greatly increased at CKD stage 2 and 3. The prevention and treatment of LVH should begin at CKD stage 2—3 so as to reduce the incidence of cardiovascular events before starting dialysis. UCG should be chosen as an examination for earlier detection of CVD in CKD patients. The screening and prevention of CVD should begin at CKD stage 1.